It has a 38.92 P/E ratio. The firm offers pizzas under the DominoÂ's Pizza brand name through company-owned and franchised DominoÂ's Pizza stores.
In the past 5 years, the stock showed growth of 21.66% per annum. The hedge fund run by Jim Simons held 3.22 million shares of the food distributors company at the end of 2017Q3, valued at $639.79M, up from 3.06 million at the end of the previous reported quarter. About 120,721 shares traded. Visa Inc. (NYSE:V) has risen 20.29% since January 11, 2017 and is uptrending. It has outperformed by 6.29% the S&P500. And, as other pizza chains have struggled, Domino's announced in October that the company grew global retail sales by 14.5% in the most recent quarter.
WARNING: "Domino's Pizza (NYSE:DPZ) Earns Buy Rating from Analysts at Deutsche Bank" was published by TrueBlueTribune and is the property of of TrueBlueTribune.
Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year's free cash flow.
Domino's Pizza, Inc. on 9/29/2017 reported its EPS as $1.48 with the analysts projecting the EPS of the stock as $1.44. Domino's Pizza's optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. Year-to-date it jumped 7.12%. Following the completion of the transaction, the insider now directly owns 17,563 shares of the company's stock, valued at $3,424,785. The Nevada-based Navellier & Associates Inc has invested 1.8% in the stock. Domino's Pizza's dividend payout ratio (DPR) is presently 35.05%.
The consensus recommendation, according to Zacks Investment research, is 2.13. On the opposite end, shares have been trading 25.85% away from the 50-day low price. AXA now owns 85,000 shares of the restaurant operator's stock valued at $16,877,000 after buying an additional 4,600 shares during the period. DPZ was included in 3 notes of analysts from October 4, 2016. Maxim Group downgraded the shares of DPZ in report on Tuesday, April 12 to "Hold" rating. Msd Capital LP who had been investing in Dineequity Inc for a number of months, seems to be bullish on the $902.83 million market cap company. 621.08 million shares or 1.52% more from 611.76 million shares in 2017Q2 were reported.
Qualcomm Inc decreased its stake in Qualcomm Inc (QCOM) by 2.35% based on its latest 2017Q3 regulatory filing with the SEC. About 296,471 shares traded. Commonwealth Of Pennsylvania School Empls Retrmt has 0.02% invested in Domino's Pizza, Inc. It has outperformed by 45.36% the S&P500.
After all, what could be a better fit than a man who took awful pizza and managed to return a 1,300% increase to investors during his reign?
Since August 9, 2017, it had 0 buys, and 1 insider sale for $616,871 activity. It dived, as 39 investors sold DPZ shares while 105 reduced holdings. 67 funds opened positions while 219 raised stakes.
Investors may be interested in viewing the Gross Margin score on shares of Domino's Pizza, Inc. (NYSE:DPZ). Pacad Inv Ltd holds 1,300 shares. Massachusetts-based Massachusetts Com Ma has invested 1.79% in Visa Inc. Legal And General Grp Inc Public Ltd Com owns 225,343 shares or 0.03% of their USA portfolio. Pacific Glob Management Company invested in 8,558 shares. Jolley Asset Management Ltd holds 2.19% or 43,783 shares in its portfolio. Alliancebernstein Limited Partnership has 27,310 shares for 0% of their portfolio. American Grp holds 0% of its portfolio in DineEquity, Inc. (NYSE:V) for 29,551 shares. Manatuck Hill Partners Ltd Liability owns 795,000 shares.
Among 26 analysts covering YUM! Therefore 83% are positive. DineEquity had 23 analyst reports since August 19, 2015 according to SRatingsIntel. The firm now has a "buy" rating on the restaurant operator's stock. The rating was upgraded by Vetr to "Strong-Buy" on Tuesday, September 8. On Friday, October 13 the stock rating was maintained by Barclays Capital with "Equal-Weight". The firm has "Buy" rating given on Friday, December 22 by Maxim Group. (NYSE:DIN) on Tuesday, August 9 with "Buy" rating.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has a beta of 1.47, compared to a beta of 1 for the market, which implies that the stock's price movements are more extreme than the market as a whole. The firm has "Buy" rating given on Wednesday, October 19 by BTIG Research. The firm has "Buy" rating by Maxim Group given on Monday, October 12. As per Wednesday, February 15, the company rating was initiated by Loop Capital. The rating was maintained by Oppenheimer with "Hold" on Wednesday, July 26.